A Targeted Amino Acid Supplement for People With Parkinson's Disease

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Parkinson Disease, Idiopathic
Interventions
DRUG

Amino acid supplement

a targeted amino acid supplement designed to provide dietary nutrients that are commonly deficient in people with PD while minimizing interference with L-Dopa medication

DIETARY_SUPPLEMENT

Whey Protein Supplement

Whey protein is one of the primary proteins found in all dairy products. It is a complete protein as it contains all the essential amino acids. We will use a 20 gram dose.

DIETARY_SUPPLEMENT

Isonitrogenous Placebo Supplement

The control supplement used in this study is an isonitrogenous placebo beverage. This supplement will consist of an inert amino acid (alanine) with the same amino acid load as the whey protein and the targeted amino acid supplement (16.2 grams).

Trial Locations (1)

06030-3805

UConn Health, Clinical Research Center, Farmington

All Listed Sponsors
lead

UConn Health

OTHER

NCT06954662 - A Targeted Amino Acid Supplement for People With Parkinson's Disease | Biotech Hunter | Biotech Hunter